-
Product Insights
Digital Health Market Size, Share and Trends Analysis by Region, Product, Technology (Telemedicine, mHealth, Digital Therapeutics, Others), Therapy Area (Dermatology, Rheumatology, Gastroenterology) and Segment Forecast, 2022-2027
The digital health in immunology market size was valued at US$6.07 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 24.2% during 2022-2027. Digital health has a broad scope and includes the use of wearable devices, mobile health, telehealth, health information technology, and telemedicine. Digital health applications in immunology have gained significant momentum owing to the following factors: Enhanced access to healthcare Affordable cost of healthcare Improve the quality of care Reduce any...
-
Sector Analysis
Rheumatoid Arthritis - Epidemiology Forecast to 2027
Rheumatoid arthritis (RA) is an autoimmune disease characterized by inflammation of the joints, bone and cartilage erosion, and joint deformity. Additionally, the condition manifests itself in multiple joints in the body. In RA, the body’s immune system attacks the lining of the joints, known as the synovial membrane, or synovium, causing an inflammatory respons. The disease can lead to premature mortality, disability, and decreased quality of life. GlobalData epidemiologists used sources that provided the diagnosed incidence, diagnosed prevalence, and total...
-
Sector Analysis
Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2027
Rheumatoid arthritis (RA) is an autoimmune disease that, due to a complex interplay of environmental, immunological, and genetic factors, causes chronic inflammation and progressive deformity of the joints over time. In 2017, the diagnosed prevalence of RA in the 8MM averaged 0.66% in adults 18 years of age and older and 2.7% in adults aged 60 and older. Early RA typically presents as a bilateral inflammatory joint condition, usually beginning in the smaller joints such as the fingers and toes...
-
Consumer Insights
KOL Perspectives: Treatment strategies for pregnant RA patients
This KOL Insight briefing focuses on KOLs views of Treatment strategies for pregnant RA patients
-
Consumer Insights
KOL Perspectives: Rituximab Use in Lupus
This KOL Insight briefing focuses on KOLs views of Rituximab Use in Lupus
-
Consumer Insights
KOL Perspectives: Upadacitinib for Rheumatoid Arthritis
› This KOL Insight briefing focuses on perceptions of novel upadacitinib data in RA
-
Consumer Insights
KOL Perspectives: BTK Inhibitors in RA
This KOL Insight briefing focuses on KOLs views of BTK Inhibitors in RA
-
Product Insights
Stem Cell Transplantation Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Stem Cell Transplantation Global Clinical Trials Review, H2, 2018" provides an overview of Stem Cell Transplantation clinical trials scenario. This report provides top line data relating to the clinical trials on Stem Cell Transplantation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Systemic Lupus Erythematosus Global Clinical Trials Review, H2, 2018" provides an overview of Systemic Lupus Erythematosus clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Lupus Erythematosus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
-
Product Insights
Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Systemic Sclerosis (Scleroderma) Global Clinical Trials Review, H2, 2018" provides an overview of Systemic Sclerosis (Scleroderma) clinical trials scenario. This report provides top line data relating to the clinical trials on Systemic Sclerosis (Scleroderma). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.